Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System.
Laura Catherine EdneyHossein Haji Ali AfzaliTerence Chai ChengJonathan KarnonPublished in: PharmacoEconomics (2019)
Recent public summary documents suggest new technologies with ICERs above AUD40,000 per QALY gained are recommended for public funding. The empirical reference ICER reported in this article suggests more QALYs could be gained if resources were allocated to other forms of health spending.